Aligos Therapeutics to Host KOL Event to Discuss ALG-000184 Phase 1, AASLD Late Breaker Data : vimarsana.com

Aligos Therapeutics to Host KOL Event to Discuss ALG-000184 Phase 1, AASLD Late Breaker Data

Aligos Therapeutics to Host KOL Event to Discuss ALG-000184 Phase 1, AASLD Late Breaker Data

tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , Philadelphia , Pennsylvania , Temple University , America , American , Veronica Eames , Mark Sulkowski , Corey Davis , American Association Of Liver Disease On , American Society For Clinical Investigation , Lifesci Communications , Department Of Medicine , Exchange Commission , Aligos Therapeutics Inc , Viral Hepatitis Center , Infectious Diseases Society Of America , Johns Hopkins University School Of Medicine , Nasdaq , Medicine At Duke University School Of , Clinical Trials Group , Temple University School Of Medicine , Exchange Commission On , American Association Of Physicians , Johns Hopkins University School , Late Breaking , American Association , Liver Disease , Infectious Diseases , Johns Hopkins Bayview Medical , Medical Director , Senior Associate Dean , Temple University School , Internal Medicine , Duke University School , New England Journal , Hepatitis Transformative Sciences Group , National Institute , Trials Group , American Society , Clinical Investigation , Liver Diseases , European Association , Infectious Diseases Society , Clinical Infectious Diseases , Highly Cited Researcher , Clarivate Analytics , Securities Litigation Reform Act , Aligo Quarterly Report ,